News Archive
Dr. Tak Mak was named amongst the 2015 RBC Top 25 Canadian Immigrants, a people’s choice program that celebrates inspiring and influential Canadian immigrants. As one of the world’s most cited and accomplished scientists, Dr. Mak was selected for his impact in cancer research.
Princess Margaret Cancer Centre and LifeLabs work together to provide comprehensive genomic profiling to thousands of Canadian cancer patients
As The Princess Margaret Cancer Foundation continues to raise funds for one of the top 5 cancer research centres in the world, we’re asked often: Why is The Princess Margaret a world leader?
A new study indicates that vaccinating 12-year-old boys against the humanpapilloma virus (HPV) may be a cost-effective strategy for preventing oropharyngeal squamous cell cancer, a cancer that starts at the back of the throat and mouth, and involves the tonsils and base of the tongue.
The Princess Margaret Cancer Centre is proud of the work accomplished by its extraordinary staff. Several of the outstanding scientists and clinicians at the Princess Margaret Cancer Centre have recently been recognized for excellence in their specific areas of expertise.
Researchers at Princess Margaret Cancer Centre are proposing a new model to enable doctors to predict outcomes more accurately for patients with throat cancers specifically caused by Human Papillomavirus (HPV).
Today, on World Cancer Day, The Princess Margaret Cancer Foundation’s #NoHairSelfie digital fundraising campaign is well-positioned to trend on social media in an effort to show support for patients worldwide who are undergoing cancer treatment.
Princess Margaret Cancer Centre is leading the way with Canada’s most comprehensive Immune Therapy program. The Globe and Mail’s science reporter Ivan Semeniuk shares the story.
On Dec. 18, Princess Margaret Cancer Centre's Drs. John Dick and Robert Bristow were selected by the Canadian Cancer Society as one of their Top 10 Research Stories of the Year.
Scientists at Princess Margaret Cancer Centre, led by Dr. Ralph DaCosta, have been experimenting with different molecular imaging modalities (fluorescence and photoacoustic imaging) to probe and target the biomarker HER2, an indicator of one of the more aggressive types of breast cancer.
Dr. Frances Shepherd has led a multi-disciplinary team of cancer specialists that has changed the standard of care for lung cancer patients around the world. In February 2015, she will once again be recognized for her achievements as she receives the Claude Jacquillat Award from the International Congress on Anti-Cancer treatment.
Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy.
The findings are published online today in Lancet Oncology. Study co-leads Dr. Robert Bristow, a clinician-scientist at Princess Margaret Cancer Centre, and Dr. Paul Boutros, an investigator at the Ontario Institute for Cancer Research, report that the gene test provides a much-needed quick and accurate tool to determine with greater precision the men who will do well with local treatment only (surgery or radiation), and those who will need extra treatment (chemotherapy and hormone therapy) to ensure the cancer is completely eradicated.
“This is a golden day,” stated Paul Alofs, President & CEO of The Princess Margaret Cancer Foundation “We are announcing a key milestone in our five-year Billion Dollar Challenge to lead the way in Personalized Cancer Medicine with an unprecedented investment in people, purpose-built space and technology. This will further the Princess Margaret Cancer Centre’s position as one of the top 5 cancer research centres in the world.”
This year, under the leadership of Dr. David Jaffray, The Princess Margaret begins operation of two first-in-the-world magnetic resonance (MR)-guided radiation therapy suites.
Halfway through its Billion Dollar Challenge, The Princess Margaret Cancer Foundation announces an unprecedented number of transformational investments that will deliver on the promise of Personalized Cancer Medicine
The Terry Fox Foundation has awarded $6.6 million to a team of researchers led by Drs. Bradly Wouters and Robert Bristow, both Senior Scientists at Princess Margaret Cancer Centre.
Dr. Tak Mak from the Princess Margaret Cancer Centre was featured as one of The Globe and Mail's "Innovators at Work." Learn about the mind of one of the most cited medical scientists in the world.
"I am very happy to be able to send this message and tell you that we have concluded our international search for UHN's President & CEO and that Dr. Peter Pisters will be joining us on January 1, 2015," states John Mulvihill, Chair of the Board of Trustees at the University Health Network.
The Princess Margaret Cancer Foundation (The PMCF) congratulates some of our world-class, distinguished individuals on their recent appointments and awards.
The American Society of Therapeutic Radiation Oncology (ASTRO) has announced that Dr. Mary Gospodarowicz, Medical Director of the Princess Margaret Cancer Centre, has been chosen to receive the ASTRO Gold Medal.
Princess Margaret Cancer Centre, in collaboration with colleagues at the Dana-Farber Cancer Institute in Boston, has published findings from the largest clinical study to evaluate breast cancer screening of female survivors of childhood Hodgkin Lymphoma (HL).
Written and directed by Toronto filmmaker Joseph Nanni, 'A DAY WITHOUT CANCER' is a 75-minute exploration of cancer's history, and poses the provocative question, "Can we conquer cancer in our lifetime?"
The Princess Margaret Cancer Foundation is very proud to announce that pioneering scientist, Dr. John Dick, a Senior Scientist at the Princess Margaret Cancer Centre, has been named a Fellow in The Royal Society.
"It's a tremendous endorsement of our work and our reputation that so many world-leading scientists and clinician-scientists have relocated to the Princess Margaret Cancer Centre to continue their important research in areas critical to Personalized Cancer Medicine," explains Dr. Benjamin Neel, Research Director.
Scientists led by Drs. Mona Gauthier and Tak Mak at The Campbell Family Institute for Breast Cancer Research at the Princess Margaret Cancer Centre have solved a key piece in the puzzle of how BRCA1 gene mutations specifically predispose women to breast and ovarian cancers.
In a media event held this morning, two of the world’s most acclaimed cancer researchers, Drs. Tak Mak of the Princess Margaret Cancer Centre, and Dennis Slamon of the University of California, Los Angeles, shared news of a major breakthrough in the decade-long pursuit to develop a new class of “sharpshooter” cancer drugs.